newsfilter
← Latest News
GlobeNewswire·

TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option

FORT WORTH, Texas, Aug. 17, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) (the "Company"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug